Story · Medicine & Biotech · Nutrition
Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial
1 outlet · first reported by medRxiv (all subjects) 14d ago
Coverage, in order
-
14d agoPsilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial
Background. Change in cognitive control is a candidate transdiagnostic mechanism of psychedelic therapy. One account predicts that, once acute effects resolve, psilocybin shifts control toward flexibility while sparing inhibition and working memory. A motivational account (PRISM) predicts that…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.